• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性血栓性血小板减少性紫癜合并胎儿死亡病例中的高凝状态及炎症标志物

Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise.

作者信息

Skeith Leslie, Hurd Kelle, Chaturvedi Shruti, Chow Lorraine, Nicholas Joshua, Lee Adrienne, Young Daniel, Goodyear Dawn, Soucie Jennifer, Girard Louis, Dufour Antoine, Agbani Ejaife O

机构信息

Department of Family Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

J Clin Med. 2022 Nov 30;11(23):7115. doi: 10.3390/jcm11237115.

DOI:10.3390/jcm11237115
PMID:36498688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9737388/
Abstract

BACKGROUND

Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder caused by an inherited genetic deficiency of ADAMTS13 and affects less than one per million individuals. Patients who are diagnosed with TTP during pregnancy are at increased risk of maternal and fetal complications including fetal demise. We present a case of a 32-year-old G3P0 (gravida 3, para 0) who presented at 20 weeks gestation with a new diagnosis of congenital TTP (cTTP) and fetal demise.

METHODS

We describe the pathophysiology of pregnancy complications in a patient with cTTP using platelet procoagulant membrane dynamics analysis and quantitative proteomic studies, compared to four pregnant patients with gestational hypertension, four pregnant patients with preeclampsia, and four healthy pregnant controls.

RESULTS

The cTTP patient had increased P-selectin, tissue factor expression, annexin-V binding on platelets and neutrophils, and localized thrombin generation, suggestive of hypercoagulability. Among 15 proteins that were upregulated, S100A8 and S100A9 were distinctly overexpressed.

CONCLUSIONS

There is platelet-neutrophil activation and interaction, platelet hypercoagulability, and proinflammation in our case of cTTP with fetal demise.

摘要

背景

先天性血栓性血小板减少性紫癜(cTTP)是一种由遗传性ADAMTS13基因缺陷引起的罕见疾病,每百万人口中发病者少于1人。孕期被诊断为TTP的患者发生母婴并发症的风险增加,包括胎儿死亡。我们报告一例32岁、孕3产0的患者,在妊娠20周时被诊断为先天性TTP(cTTP)并出现胎儿死亡。

方法

与4例妊娠期高血压孕妇、4例先兆子痫孕妇及4例健康孕妇对照相比,我们通过血小板促凝膜动力学分析和定量蛋白质组学研究,描述了1例cTTP患者妊娠并发症的病理生理学情况。

结果

该cTTP患者的P-选择素、组织因子表达、血小板和中性粒细胞上膜联蛋白-V结合以及局部凝血酶生成增加,提示存在高凝状态。在15种上调的蛋白质中,S100A8和S100A9明显过度表达。

结论

在我们这例伴有胎儿死亡的cTTP患者中,存在血小板-中性粒细胞激活与相互作用、血小板高凝状态及炎症反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99d/9737388/a2e8f25ea2f1/jcm-11-07115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99d/9737388/a2e8f25ea2f1/jcm-11-07115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f99d/9737388/a2e8f25ea2f1/jcm-11-07115-g001.jpg

相似文献

1
Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise.先天性血栓性血小板减少性紫癜合并胎儿死亡病例中的高凝状态及炎症标志物
J Clin Med. 2022 Nov 30;11(23):7115. doi: 10.3390/jcm11237115.
2
Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura.血浆治疗先天性血栓性血小板减少性紫癜孕妇的成功与局限性
J Thromb Haemost. 2020 Nov;18(11):2929-2941. doi: 10.1111/jth.15064. Epub 2020 Oct 15.
3
Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases.揭示妊娠相关先天性血栓性血小板减少性紫癜的病理生理学:一系列家族性病例的启示。
Am J Obstet Gynecol. 2021 Aug;225(2):177.e1-177.e15. doi: 10.1016/j.ajog.2021.02.018. Epub 2021 Feb 20.
4
Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes.血栓性血小板减少性紫癜与妊娠:临床表现、处理方法及后续妊娠结局。
Blood. 2014 Jul 10;124(2):211-9. doi: 10.1182/blood-2014-02-553131. Epub 2014 May 23.
5
First reported case of congenital thrombotic thrombocytopenic purpura in Taiwan with novel mutation of ADAMTS13 gene.台湾首例先天性血栓性血小板减少性紫癜病例,伴有 ADAMTS13 基因突变。
Int J Hematol. 2021 May;113(5):760-764. doi: 10.1007/s12185-020-03068-5. Epub 2021 Jan 2.
6
Frequent recurrence of pregnancy-triggered congenital thrombotic thrombocytopenic purpura: A rare case report.妊娠相关性先天性血栓性血小板减少性紫癜频繁复发:罕见病例报告。
Clin Hemorheol Microcirc. 2021;77(2):195-200. doi: 10.3233/CH-200970.
7
Congenital thrombotic thrombocytopenic purpura presenting in adulthood with recurrent cerebrovascular events.成年期出现的先天性血栓性血小板减少性紫癜伴复发性脑血管事件。
BMJ Case Rep. 2019 Oct 3;12(10):e229481. doi: 10.1136/bcr-2019-229481.
8
A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.一例以妊娠期血栓性血小板减少性紫癜为表现的严重ADAMTS13缺乏症病例。
Med Pregl. 2012 Sep-Oct;65(9-10):436-9. doi: 10.2298/mpns1210436n.
9
Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.一项针对血小板减少孕妇的回顾性研究中产科血栓性血小板减少性紫癜的发病率。一种诊断困难但可治疗的疾病。
BMC Pregnancy Childbirth. 2015 Jun 17;15:137. doi: 10.1186/s12884-015-0557-5.
10
Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report.孕期表现为免疫性血小板减少性紫癜的遗传性血栓性血小板减少性紫癜:一例报告
J Med Case Rep. 2018 Jan 22;12(1):15. doi: 10.1186/s13256-017-1545-3.

引用本文的文献

1
Thrombotic Thrombocytopenic Purpura in Pediatric Patients.儿童患者的血栓性血小板减少性紫癜
Biomedicines. 2025 Apr 25;13(5):1038. doi: 10.3390/biomedicines13051038.
2
Etiology and outcomes: Thrombotic microangiopathies in pregnancy.病因与预后:妊娠期血栓性微血管病
Res Pract Thromb Haemost. 2023 Feb 13;7(2):100084. doi: 10.1016/j.rpth.2023.100084. eCollection 2023 Feb.
3
Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers.子痫前期:血小板促凝膜动力学及关键生物标志物

本文引用的文献

1
Platelets and neutrophils co-drive procoagulant potential in secondary antiphospholipid syndrome during pregnancy.血小板和中性粒细胞共同驱动妊娠期间继发性抗磷脂综合征的促凝潜能。
Thromb Res. 2022 Dec;220:141-144. doi: 10.1016/j.thromres.2022.10.018. Epub 2022 Nov 3.
2
Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura.免疫介导的血栓性血小板减少性紫癜诊断后妊娠的母婴结局
Ann Hematol. 2022 Oct;101(10):2159-2167. doi: 10.1007/s00277-022-04936-2. Epub 2022 Aug 6.
3
Thrombotic thrombocytopenic purpura and severe preeclampsia: a clinical overlap during pregnancy and a possible coexistence.
Res Pract Thromb Haemost. 2023 Feb 8;7(2):100075. doi: 10.1016/j.rpth.2023.100075. eCollection 2023 Feb.
血栓性血小板减少性紫癜与重度子痫前期:妊娠期的临床重叠及可能的共存。
J Gynecol Obstet Hum Reprod. 2022 Sep;51(7):102422. doi: 10.1016/j.jogoh.2022.102422. Epub 2022 Jun 7.
4
Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia.妊娠期高血压和子痫前期血小板及血浆中血栓-炎症介质的蛋白质组学和代谢组学分析。
Cells. 2022 Apr 7;11(8):1256. doi: 10.3390/cells11081256.
5
Early ADAMTS13 testing associates with pre-eclampsia occurrence in antiphospholipid syndrome.早期ADAMTS13检测与抗磷脂综合征中先兆子痫的发生相关。
Thromb Res. 2021 Jul;203:101-109. doi: 10.1016/j.thromres.2021.04.021. Epub 2021 Apr 27.
6
Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura.遗传性血栓性血小板减少性紫癜急性发作的年发病率及严重程度
Blood. 2021 Jun 24;137(25):3563-3575. doi: 10.1182/blood.2020009801.
7
Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases.揭示妊娠相关先天性血栓性血小板减少性紫癜的病理生理学:一系列家族性病例的启示。
Am J Obstet Gynecol. 2021 Aug;225(2):177.e1-177.e15. doi: 10.1016/j.ajog.2021.02.018. Epub 2021 Feb 20.
8
Hereditary Thrombotic Thrombocytopenic Purpura.遗传性血栓性血小板减少性紫癜
N Engl J Med. 2019 Oct 24;381(17):1653-1662. doi: 10.1056/NEJMra1813013.
9
Characterization and treatment of congenital thrombotic thrombocytopenic purpura.先天性血栓性血小板减少性紫癜的特征与治疗。
Blood. 2019 Apr 11;133(15):1644-1651. doi: 10.1182/blood-2018-11-884700. Epub 2019 Feb 15.
10
Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis.水通道蛋白-1 调节血小板促凝膜动力学和体内血栓形成。
JCI Insight. 2018 May 17;3(10). doi: 10.1172/jci.insight.99062.